Chief Financial Officer

Mr. O’Connell has deep expertise and understanding of both the life science and technology industries, including leading fundraisings, public listings, acquisitions and trade sales. With over 25 years experience, Mr. O’Connell previously served as the CFO and Director of Escher Group Holdings, a listed technology company. Before this he was CFO and Director of Merrion Pharmaceuticals PLC at the time the company was listed, and he subsequently became its CEO. He also served as CFO and Director of Trinity Biotech, where he managed their listing on the NASDAQ and also the Irish Stock Exchange. In his earlier career Mr. O’Connell was with Arthur Andersen. He is a Fellow of Chartered Accountants Ireland, with the Associate Chartered Accountant (ACA) designation. Mr. O’Connell holds a Bachelor of Business Studies from Trinity College Dublin.